Clinical trial
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone…
NCT00066573 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00066573 |
|---|---|
| Title | Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer |
| Official title | A Randomized Phase III Trial Of Exemestane Versus Anastrozole In Postmenopausal Women With Receptor Positive Primary Breast Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group Cancer and Leukemia Group B Eastern Cooperative Oncology Group SWOG Cancer Research Network ETOP IBCSG Partners Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | anastrozole, exemestane |
| Enrollment | 7,576 |
| Start date | Jun 6, 2003 |
| Primary completion | Nov 7, 2010 |
| Completion | Jan 6, 2012 |
| First posted | Aug 7, 2003 |
| Last update posted | Aug 25, 2023 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: